Auris Medical (EARS) Stock Price & Overview

NASDAQ:EARS

Current stock price

3.045
-0.06 (-1.77%)
At close:
3.02
-0.02 (-0.82%)
After Hours:

The current stock price of EARS is 3.045 null. Today EARS is down by -1.77%. In the past month the price decreased by -13.49%. In the past year, price increased by 204.56%.

EARS Key Statistics

52-Week Range0.7255 - 6.6
Current EARS stock price positioned within its 52-week range.
1-Month Range2.8 - 3.75
Current EARS stock price positioned within its 1-month range.
Market Cap
34.765M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-1.45
Dividend Yield
N/A

EARS Stock Performance

Today
-1.77%
1 Week
+3.57%
1 Month
-13.49%
3 Months
-8.83%
Longer-term
6 Months -7.16%
1 Year +204.56%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

EARS Stock Chart

Auris Medical / EARS Daily stock chart

EARS Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to EARS. When comparing the yearly performance of all stocks, EARS is one of the better performing stocks in the market, outperforming 94.61% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
EARS Full Technical Analysis Report

EARS Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to EARS. Both the profitability and financial health of EARS have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
EARS Full Fundamental Analysis Report

EARS Earnings

Next Earnings DateN/A
Last Earnings DateN/A
PeriodQ1 / 2021
EPS Reported-CHF1.36
Revenue Reported
EPS Surprise %
Revenue Surprise %
EARS Earnings History

EARS Forecast & Estimates


Analysts
Analysts0
Price TargetN/A
EPS Next Y0%
Revenue Next YearN/A
EARS Forecast & Estimates

EARS Groups

Sector & Classification

Sub-Industry
Pharmaceuticals
Index Membership

EARS Financial Highlights

Over the last trailing twelve months EARS reported a non-GAAP Earnings per Share(EPS) of -1.45. The EPS increased by 36.79% compared to the year before.


Income Statements
Revenue(TTM)N/A
Net Income(TTM)-8.75M
Industry RankSector Rank
PM (TTM) N/A
ROA -105.84%
ROE N/A
Debt/Equity 0.01
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)36.79%
Revenue 1Y (TTM)N/A
EARS financials

EARS Ownership

Ownership
Inst Owners6.03%
Shares11.42M
Float11.42M
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
EARS Ownership

EARS Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
LLY ELI LILLY & CO 26.65900.456B
JNJ JOHNSON & JOHNSON 20.99587.99B
MRK MERCK & CO. INC. 23.15298.764B
PFE PFIZER INC 9.51162.403B
BMY BRISTOL-MYERS SQUIBB CO 9.37125.711B
ZTS ZOETIS INC 16.5749.512B
RPRX ROYALTY PHARMA PLC- CL A 9.4727.972B
VTRS VIATRIS INC 5.3515.693B
ELAN ELANCO ANIMAL HEALTH INC 21.511.495B
AXSM AXSOME THERAPEUTICS INC N/A8.787B
BLTE BELITE BIO INC - ADR N/A6.274B
TERN TERNS PHARMACEUTICALS INC N/A5.606B
CORT CORCEPT THERAPEUTICS INC 52.314.465B

Related stock screener links

View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges

About EARS

Company Profile

EARS logo image Auris Medical Holding Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders. The company is headquartered in Zug, Zug and currently employs 9 full-time employees. The company went IPO on 2014-08-06.

Company Info

IPO: 2014-08-06

Auris Medical

Bahnhofstrasse 21

Zug ZUG HM 11 CH

CEO: Thomas Meyer

Employees: 9

EARS Company Website

Phone: 410612011350.0

Auris Medical / EARS FAQ

What does Auris Medical do?

Auris Medical Holding Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders. The company is headquartered in Zug, Zug and currently employs 9 full-time employees. The company went IPO on 2014-08-06.


Can you provide the latest stock price for Auris Medical?

The current stock price of EARS is 3.045 null. The price decreased by -1.77% in the last trading session.


Does Auris Medical pay dividends?

EARS does not pay a dividend.


What is the ChartMill technical and fundamental rating of EARS stock?

EARS has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


Where is Auris Medical (EARS) stock traded?

EARS stock is listed on the Nasdaq exchange.


Can you provide the number of employees for Auris Medical?

Auris Medical (EARS) currently has 9 employees.


Can you provide the market cap for Auris Medical?

Auris Medical (EARS) has a market capitalization of 34.76M null. This makes EARS a Nano Cap stock.